Related Experiment Video
Updated: Jun 6, 2026

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model
Published on: February 8, 2022
Idiopathic intracranial hypertension
1Departments of Neurology and Ophthalmology, Upstate Medical University, 90 Presidential Plaza, Syracuse, NY, 13202, USA, kom@upstate.edu.
Weight loss is a key treatment for idiopathic intracranial hypertension (IIH) in overweight patients. Acetazolamide may help symptoms, while surgery is reserved for severe vision loss or headache.
Area of Science:
- Neurology
- Ophthalmology
Background:
- Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure of unknown cause.
- Weight management is a crucial long-term strategy for overweight or obese patients diagnosed with IIH.
Purpose of the Study:
- To outline current treatment strategies for idiopathic intracranial hypertension.
- To discuss the role of medical and surgical interventions in managing IIH symptoms and vision loss.
Main Methods:
- Review of established and emerging treatments for IIH.
- Discussion of weight reduction, acetazolamide, and surgical interventions (optic nerve sheath fenestration, CSF diversion).
- Mention of the ongoing Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).
Main Results:
- Weight reduction (5-10%) is recommended for overweight/obese IIH patients.
- Acetazolamide may aid symptom management, though not definitively proven.
- Surgical options are considered for severe vision loss or intractable headaches.
Conclusions:
- Treatment for IIH is often individualized based on patient factors and clinical presentation.
- Further data from the IIHTT will clarify the efficacy of acetazolamide and lifestyle interventions.
Related Concept Videos
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Cerebral Edema l: Introduction
Hemorrhagic Stroke l: Introduction
Cytotoxic Edema: Pathophysiology
